ARIAD Offers Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer
September 29, 2014 at 07:36 AM EDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced updated clinical results on its investigational tyrosine kinase inhibitor ...